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Abstract
Background: Lower extremity amputations are costly and debilitating complications in patients with diabetes
mellitus (DM). Our aim was to investigate changes in the amputation rate in patients with DM at the Karolinska
University Hospital in Solna (KS) following the introduction of consensus guidelines for treatment and prevention
of diabetic foot complications, and to identify risk groups of lower extremity amputations that should be targeted
for preventive treatment.
Methods: 150 diabetic and 191 nondiabetic patients were amputated at KS between 2000 and 2006; of these 102
diabetic and 99 nondiabetic patients belonged to the catchment area of KS. 21 diabetic patients who belonged to
KS catchment area were amputated at Danderyd University Hospital. All patients’ case reports were searched for
diagnoses of diabetes, vascular disorders, kidney disorders, and ulcer infections of the foot.
Results: There was a 60% reduction in the rate of amputations performed above the ankle in patients with DM
during the study period. Patients with DM who underwent amputations were more commonly affected by foot
infections and kidney disorders compared to the nondiabetic control group. Women with DM were 10 years older
than the men when amputated, whereas men with DM underwent more multiple amputations and had more foot
infections compared to the women. 88% of all diabetes-related amputations were preceded by foot ulcers. Only
30% of the patients had been referred to the multidisciplinary foot team prior to the decision of amputation.
Conclusions: These findings indicate a reduced rate of major amputations in diabetic patients, which suggests an
implementation of the consensus guidelines of foot care. We also propose further reduced amputation rates if
patients with an increased risk of future amputation (i.e. male sex, kidney disease) are identified and offered
preventive treatment early.
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Introduction
Foot ulcers are frequent and costly complications of dia-
betes [1], and the most common risk factor of lower
extremity amputations (LEA) in diabetic patients [2,3].
Although debated, the rate of LEA has been considered
an indicator of the quality of diabetic foot care [4].
Common diabetic complications such as peripheral neu-
ropathy and peripheral vascular disease contribute to
the formation of foot ulcers, the latter by causing ische-
mia, gangrene and impaired wound healing [5,6]. A
common occurrence of ulcer infections in patients with
foot ulcers is a contributing risk factor for LEA [7],
along with renal disorders [8].
The St. Vincent Declaration was published in 1989 to
set 5-year targets for the quality level of diabetes care in
Europe [9]. In 1998 the Swedish Medical Research
Council published “Consensus statement. Foot problems
of Diabetics”, and in 2000 the International Working
Group on the Diabetic Foot published the “International
Consensus on the Diabetic Foot and Practical Guidelines
on the Management and the Prevention of the Diabetic
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prevention of the diabetic foot, stressing the importance
of a multidisciplinary approach in order to ensure the
most effective treatment [10,11]. Following these impor-
tant publications several multidisciplinary studies have
shown a decreased LEA rate following the introduction
of national prevention programs and the establishment
of multidisciplinary treatment teams for diabetic foot
ulcers [12-14]. Consistently, multidisciplinary treatment
teams headed by diabetologists have been applied at the
Department of Endocrinology, Metabolism and Diabetes
(DEMD) at the Karolinska University Hospital in Solna
(KS) since the early 1990s. The primary care centers
and hospitals in the region have repeatedly been offered
theoretical educational courses on the preventive care of
the diabetic foot, as well as in the treatment of diabetic
foot complications. The aim of this study was to investi-
gate clinical characteristics of diabetic patients ampu-
tated at KS, and to evaluate the impact of an
implementation of the national and international guide-
lines on the diabetic foot by investigating the amputa-
tion rate. Since all personnel involved in the treatment
of the diabetic foot at KS have to undergo education,
including lectures and practical training, we decided to
address the possible impact by investigating the treat-
ment outcome, rather than by using surveys or inter-
views. Our hypothesis was that an awareness of the
consensus guidelines will increase the quality of health
care among all healthcare units and specialists in the
multidisciplinary teams. Thus, prevention and treatment
of diabetic foot ulcers will be more efficient, ultimately
resulting in a reduced amputation rate in patients with
diabetes. In this study, we report a reduction in the rate
of amputations performed above the ankle in patients
with diabetes treated at KS, during a period that fol-
lowed the implementation of the consensus guidelines.
We also identify risk groups that need extra attention in
order to make it possible to reduce the amputation rates
further.
Subjects, materials and methods
The study was carried out at KS between January 2000
and December 2006. The catchment area of KS included
300 000 inhabitants and approximately over 10 000 sub-
jects with diabetes during the study period, of which the
majority were treated in the primary care. All patients
who underwent orthopaedic procedures of the lower
extremities at KS during the period (n = 473) were stu-
died. The diagnoses were confirmed by searching
through the listed patients’ case reports for the event of
an amputation preceded by a known history of diabetes
mellitus. Patients who were diagnosed with diabetes
mellitus at the time of amputation were defined as dia-
betic. 150 amputated patients with diabetes were found.
191 amputated patients without a known history of dia-
betes were defined as nondiabetic. When no or too little
data could be retrieved from the patient’s case report
the patient was excluded. This was done in five cases,
including the nondiabetic control group. Data from year
2000 was not complete due to a change in electronic
case report systems at that t i m e ,t h u s ,t h i sy e a rh a dt o
be excluded from all analyses across time to minimize
the risk of underreporting. However, data collected from
patients amputated year 2000 was used for group ana-
lyses in order to increase statistical power. The case
reports of the 150 diabetic patients were searched for
diagnoses of kidney disorders, vascular disorders and
ulcer infections of the foot that were present before an
amputation. Kidney disorders were defined as acute
renal failure (ICD-10 code N17), chronic kidney disease
(N18), known diabetes nephropathy (E10.2, E11.2,
E14.2), serum creatinine levels > 100 μmol/l or kidney
transplants. Infections were defined as positive culture
of MRSA, osteomyelitis (M86), osteitis or infected
wounds of the foot or residual limb (e.g. L02.4, L98.4,
T86.4, T87.4, T81.4). Peripheral vascular disorders
(PVD) were defined as atherosclerosis (I70), ischemia
(I20), unspecified peripheral vascular disease (I73.9),
arterial embolism and thrombosis (I74), diabetic circula-
tory disorders (E10.5, E11.5, E14.5), cerebrovascular dis-
eases (I60-I69), diseases of veins (e.g. I80-I82, I87), or
ischemia of the limb. Circulatory disorders were defined
as PVD and cardiovascular disorders (CVD), the latter
including hypertensive diseases (I10-I15), ischaemic
heart diseases (I20-I25) and other forms of heart dis-
eases (I30-I52). In addition, the 150 diabetic patients’
case reports from the orthopaedic clinic were checked
for the presence of foot ulcers at the event of amputa-
tion. All amputations performed below the ankle were
defined as minor amputations, whereas amputations
above the ankle were defined as major. No Syme’s
amputations or any other talocrural level amputations
were performed. In cases where patients underwent
multiple amputations during the study period, the
amputation that was deemed to have the largest impact
on the patient’s quality of life was used for the analysis
(Figure 1A). When patients underwent several amputa-
tions on the same level during an extended period of
time, the first recorded amputation was used (Figure
1B). Repeated amputations (re-amputations) performed
within the same period of hospital care, due to poor
healing or infection, were classified as the last reported
amputation within this period (Figure 1C). Re-amputa-
tions and subsequent amputations of a contralateral
limb (double amputations) were analyzed separately.
The postal codes of the residential areas of the
patients were retrieved from registers delivered from the
Department of Orthopaedics, or from the patients’ case
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area each patient belonged. The personal identification
number, a unique 10 digit number that each resident in
Sweden get at the time of birth or following immigra-
tion, was used for gender identification. Patient registers
with personal identification numbers from the foot care
policlinic were compared with patient registers from the
orthopaedic’s charts in order to identify patients who
had been treated at the foot care clinic at the DEMD of
KS during the time period. 21 patients belonging to KS
catchment area were referred to Danderyd University
Hospital (DS) for foot care and amputation during the
investigated time period. This is the only diabetic
patient group from KS catchment area known to have
been treated at a hospital other than KS. Patients who
underwent amputations at DS were identified using
patient registers from the orthopaedic clinic at DS. Fig-
ure 1D shows the departments from which the diabetic
patients were referred for amputation, the most com-
mon being the DEMD and the Department of Vascular
Surgery. Patients from the DE M Dw e r em o s t l yr e f e r r e d
for amputation due to complications of foot ulcers,
while the majority of the patients from the Department
of Vascular Surgery were referred due to inaccessibility
for vascular intervention, failed reconstructions, or com-
plications of vascular procedures.
The multidisciplinary foot team consisted of a diabe-
tologist, a vascular surgeon, a specialist in infectious dis-
eases, a chiropodist and an orthopaedic surgeon, who all
were educated in the consensus guidelines for foot care.
At the multidisciplinary foot clinic, patients were treated
for hyperglycemia, hypertension and hyperlipidemia, and
were given the opportunity to attend programs to quit
smoking. Vascular surgeons performed percutaneous
transluminal angioplasty or bypass surgery and, when
necessary, a specialist in infectious diseases decided the
antibiotic treatment, whereas orthopaedic surgeons
decided on surgical revision and/or off-loading treat-
ment. Diabetologists were responsible for metabolic
control and, when necessary, the treatment of heart fail-
ure and kidney failure.
The diabetic and nondiabetic populations in KS catch-
ment area were estimated based on the finding that
3.5% of the population between 40 and 70 years of age
was diabetic in the geographically defined region Sund-
byberg [15]. The total population numbers of each
region in KS catchment area were retrieved from Statis-
tics Sweden [16], using the age range 40-70 years. The
diabetic population was estimated to constitute 3.5% of
the total population. The nondiabetic population was
calculated by subtracting the estimated number of dia-
betic patients from the total number of inhabitants in
each region.
Statistical analyses
STATISTICA 8 (StatSoft) and GraphPad Prism version
4.03 (GraphPad Software Inc.) were used for performing
all statistical analyses. An unpaired Student’s t-test was
used to compare the mean age in female and male
patients. Fisher’s exact test was used to test for gender
differences in the number of amputations, in the inci-
dence or prevalence of additional diagnoses and foot
ulcers, and in the referral for foot treatment. A one-way
ANOVA analysis followed by a Bonferroni post hoc test
was used to compare several groups of patients. Chi-
square test for trend was used to study linear trends
across time. A p-value < 0.05 was considered as
significant.
Results
Patients from all catchment areas
The total number of patients amputated at KS between
2000 and 2006 was 341, of which 155 (45.5%) were
females and 186 (54.5%) were males. The number of
Figure 1 Classification of amputations and selection of patients. A, B and C. The arrows indicate events of amputations. D. Referral patterns
and selection of study subjects.
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females and 93 (49%) were males. The number of dia-
betic patients amputated at KS between 2000 and 2006
was 150, of whom 57 (38%) were females and 93 (62%)
were males. During the period of investigation at least
ten different surgeons were performing amputations at
KS. More than half of the amputations at KS were done
by two surgeons with long experience (> 10 years). All
surgeons had at least two years of orthopaedic specialist
training with the same senior consultant as tutor before
the amputations were performed.
Patients from the catchment area of KS
Two hundred and one out of the 341 patients who were
amputated at KS during the study period belonged to
KS catchment area, 99 nondiabetic were amputated, of
which 54 (54.5%) were females and 45 (45.5%) were
males. In the nondiabetic group, 28 patients did not suf-
fer from any vascular disorders but were mainly ampu-
tated due to neoplasms or physical trauma, whereas 71
nondiabetic patients suffered from vascular dysfunctions
and were used as the nondiabetic control group. 102 of
the 201 patients suffered from diabetes mellitus, 37
(36.5%) were females and 65 (63.5%) were males. Fish-
er’s exact test revealed a significant difference in dia-
betes status and gender (p < 0.05), indicating that the
gender distribution was skewed towards male gender in
diabetic patients. The number of patients from KS
catchment area amputated each year is displayed in
Table 1, and the clinical characteristics are summarized
in Tables 2 and 3. 21 diabetic patients were referred for
amputations at DS during the study period, eight (38%)
females and thirteen (62%) males. These patients under-
went seventeen major and four minor amputations.
Only age, gender and amputation status could be
retrieved from these 21 patients. In order to increase
statistical power, these patients were included when cal-
culating the amputation rates.
Amputation rates
In the 71 nondiabetic patients the amputation rate (the
number of nondiabetic amputated patients divided by
the nondiabetic population in KS catchment area) was
0.09 per mille in 2001 and 0.15 per mille in 2006 (see
Figure 2A). A chi-square test for the trend did not
reveal any significant linear trend in the total number of
amputations performed throughout the study period.
The rate of major amputations remained unchanged
during the study period (p = 0.5), whereas there was a
linear trend in the rate of minor amputations, which
increased from 0.009 per mille to 0.05 per mille (p =
0.02) (data not shown). Six multiple amputations were
performed in this group, giving 1.07 amputations per
patient (see Table 2).
In the 123 diabetic patients the amputation rate chan-
ged from 5.60 per mille in 2001 to 2.4 per mille in 2006,
with a tendency of a linear trend (p =0 . 0 6 )( F i g u r e2 A
and 2B). The rate of major amputations was 4.4 per
mille in 2001 and 1.7 per mille in 2006 (p <0 . 0 5 ) ,w h i l e
the rate of minor amputations was 1.3 per mille in 2001
and 0.7 per mille in 2006 (Figure 2B) (p =0 . 2 ) .4 3m u l -
tiple (re- or double) amputations were performed in this
group, giving 1.35 amputations per patient, which was
Table 1 The nondiabetic patients with vascular
dysfunction from KS catchment area amputated at KS,
and diabetic patients from KS catchment area amputated
at KS or DS (females/males)
Year Number of
patients
Transfemoral Transtibial Major Minor
D- D+ D- D+ D- D+ D- D+ D- D+
2000 6
(3/3)
17
(7/10)
25 4 9 6 1 4 0 3
2001 10
(3/7)
22
(6/16)
44 4 1 3 8 1 7 2 5
2002 12
(8/4)
20
(6/14)
53 6 1 5 1 1 1 8 1 2
2003 4
(2/2)
14
(7/7)
0 0 4 9 4905
2004 11
(4/7)
24
(7/17)
22 7 9 9 1 1 2 1 3
2005 11
(6/5)
16
(9/7)
4 4 7 8 11 12 0 4
2006 17
(13/4)
10
(3/7)
2 2 9 51 1 763
Total 71
(39/32)
123
(45/78)
19 20 41 68 60 88 11 35
D-: patients without diabetes mellitus from the catchment area of KS
amputated at KS due to vascular dysfunction; D+: patients with diabetes
mellitus from the catchment area of KS amputated at KS or DS; major:
transfemoral and transtibial amputations; minor: amputations of foot or toe.
Re- and double amputations are not shown.
Table 2 Clinical characteristics of all amputated patients
from the catchment area of KS
D- D+
Number of patients 71 123
Mean age at first amputation 81 75 p < 0.01
Median age at first amputation 83 78
Number of amputations 77 166
Number of multiple amputations 6 (7.7%) 43 (26%) p < 0.001
Amputations per patient 1.08 1.35
Patients with kidney disorders 3 (4%) 33 (32%)* p < 0.0001
Patients with foot or limb infections 1 (14%) 17 (17%)* p < 0.0001
Patients with PVD 71 (100%) 88 (86%)* p < 0.001
Patients with PVD or CVD 71 (100%) 97 (95%)* p = 0.08
Percentages in parenthesis indicate re-amputations per amputation, and
diagnoses per patient, respectively. Multiple amputations: re- and double
amputations.
*n = 102 in the D + group.
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0.001). Male patients underwent a higher percentage of
minor amputations compared to female patients (41%
vs.2 3 % ,p < 0.05). In line with this, male patients also
underwent more multiple amputations (1.16 vs.1 . 4 6
amp. per patient, p < 0.01) (see Table 3). Amputation
rates in nondiabetic and diabetic patients from the
catchment area of KS are displayed in table 4.
Age distribution
In nondiabetic patients there was no age difference
between the sexes (Figure 3A). The mean age at the
event of amputation was 81 years (median: 83, range:
57-96) in the whole group, 83 years (median: 86, range:
71-96) in female patients and 78 years (median: 80.5,
range: 57-95) in male patients.
The subjects in the diabetic group were significantly
younger when undergoing amputations, compared to
the nondiabetic group, as revealed by a one-way
A N O V Af o l l o w e db yaB o n f e r r o n ip o s th o ct e s t( p <
0.01) (Figure 3A). In the diabetic group the mean age
was 81.5 years (median: 84) in female patients and 71.5
years (median: 72) in male patients at the event of
amputation (see Figure 3A). The female patients were
significantly older compared to the male patients (p <
0.001) when amputated. Diabetic men were significantly
younger compared to nondiabetic men (p < 0.05),
whereas there was no difference between nondiabetic
and diabetic women. Figure 3B shows the annual age
distribution in diabetic patients during the investigated
time period.
Foot ulcers in diabetic patients from the catchment area
of KS amputated at KS
31 (30%) of the 102 diabetic patients from the catch-
ment area of KS amputated at KS had been treated by
the multidisciplinary foot team as either outpatients at
the special foot clinic at the DEMD, or as inpatients at
the same department with the diagnosis of foot ulcers
(L98.4). The foot ulcer and foot care status of the 21
patients amputated at DS were not known, hence these
patients could not be included in the analysis. Out of
the 530 patients who were outpatients at the foot clinic,
Table 3 Clinical characteristics of amputated diabetic
patients from the catchment area of KS
Females Males
Number of patients 45
(36.5%)
78
(63.5%)
Mean age at first amputation 81.5 71.5 p <
0.001
Median age at first amputation 84 72
Mean age in Swedish diabetic
patients†
63.9 61.8
Number of amputations 52 114
Number of minor amputations 12 (23%) 47 (41%) p < 0.05
Number of multiple amputations 7 (12%) 36 (34%) p < 0.01
Amputations per patient 1.16 1.46
Patients with kidney disorders* 8 25 p = 0.08
Patients with foot or limb infections* 2 15 p < 0.05
Patients with PVD* 35 53 p = 0.08
Patients with PVD or CVD* 37 60
Patients affected by foot ulcers* 33 (89%) 57 (88%)
Patients visiting the foot team* 7 (19%) 24 (37%) p = 0.07
Percentages in parenthesis indicate minor amputations per amputation, re-
amputations per amputation, and diagnoses per patient, respectively. Multiple
amputations: re- and double amputations.
†NDR: The Swedish National Diabetes register, https://www.ndr.nu/NDR2/
Default.aspx
*n = 102
Figure 2 Amputation rates across time. A. Amputation rate in
nondiabetic and diabetic patients from the catchment area of KS. B.
Amputation rate in diabetic patients from the catchment area of KS.
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313 patients who were inpatients at the DEMD due to
complicated foot ulcers, 52 (17%) underwent amputa-
tions. This number is higher than 31 since also patients
from other catchment areas were treated at the foot
clinic. The most severe non-healing chronic foot ulcers
were referred from the primary care and constituted 25-
33% of all patients with foot ulcers. In total, 90 (88%) of
the 102 amputations were performed as a consequence
of foot ulcers (Table 3). There was no significant differ-
ence between the female (89%) and male (88%) patients
in the presence of foot ulcers prior to amputation (Fig-
ure 4A). However, there was a trend that more male
patients had been referred to the foot clinic of the
DEMD for foot ulcer treatment compared to the female
patients (p = 0.07). Only seven (19%) of the female
patients who were amputated had been treated as either
in- or outpatients at the DEMD during the time period,
compared to 24 (37%) of the male patients. 68% of the
patients who had been inpatients at the DEMD due to
foot ulcers (L98.4) were males (data not shown). Figure
4B shows the annual distribution of amputations per-
formed on limbs affected by foot ulcers, compared to
the distribution of patients receiving foot care. Statistical
analyses did not reveal any linear trends in the presence
of foot ulcers or foot care status over time.
Comorbidities
There were primarily two different main diagnoses regis-
tered by the orthopaedic surgeons: insulin-dependent
diabetes mellitus with peripheral circulatory complica-
tions (E10.5) and/or atherosclerosis of arteries of extre-
mities with gangrene (I70.2). The DRG registration for
diagnoses was not changed during the study period. Fig-
ures 5A and 5B show the accumulated distribution of
additional diagnoses associated with an increased risk of
LEA: circulatory disorders, foot infections, and kidney
disorders. Diabetic patients suffered from more kidney
disorders (p < 0.0001) and more foot infections (p <
0.0001) compared to nondiabetic patients amputated at
KS (see Table 2 and Figure 5A). All nondiabetic patients
suffered from vascular disorders, as this was a diagnosis
criterion used for selecting the control group, whereas
86% of the diabetic patients were affected (p < 0.001). In
the diabetic group, 17 (17%) patients suffered from severe
foot infections, a condition more common in male
patients (p < 0.05) (Figure 5B) and 33 (32%) patients suf-
fered from kidney disorders, which tended to be more
common in male patients (p = 0.08). 97 (95%) of the 102
diabetic patients suffered from circulatory disorders,
including 88 (86%) patients with PVD. There was a trend
of more PVD in female patients with diabetes (p = 0.08).
Discussion
The number of major amputations decreased roughly by
60% in patients from the catchment area of KS during
the investigated time period between 2001 and 2006.
There was a tendency of a decrease in the total number
of amputations, whereas the number of minor amputa-
tions remained stable, suggesting that diabetic patients
underwent fewer and less disabling amputations at the
end of the study period. Reductions in the total and
major amputation rates are consistent with recent stu-
dies of trends in the amputation rate [17-19] and indi-
cate an improved effectiveness in the diabetes care,
possibly due to multidisciplinary actions.
Table 4 Amputation rates in nondiabetic and diabetic patients from KS catchment area
Year Inhabitants
(40-70 years)
Nondiabetic Diabetic
Population Amputated
(f/m)
Rate
(per mille)
Population Amputated
(f/m)
Rate
(per mille)
2000 110 082 106 229 6
(3/3)
0.056 3853 17
(7/10)
4.4
2001 111 356 107 459 10
(3/7)
0.093 3897 22
(6/16)
5.6
2002 112 728 108 783 12
(8/4)
0.11 3945 20
(6/14)
5.1
2003 114 176 110 180 4
(2/2)
0.036 3996 14
(7/7)
3.5
2004 116 211 112 144 11
(4/7)
0.098 4067 24
(7/17)
5.9
2005 118 200 114 063 11
(6/5)
0.096 4137 16
(9/7)
3.9
2006 120 452 116 236 17
(13/4)
0.146 4216 10
(3/7)
2.4
Total n/a n/a 71
(39/32)
n/a n/a 123
(45/78)
n/a
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nantly male, a finding which is consistent with previous
studies [20-22]. Male patients also underwent more re-
and double amputations. The mechanisms underlying
the increased rate of LEA in male patients is not known,
but could be related to several factors, including pre-
vious smoking habits and a larger physical stress on the
feet caused by increased height and body weight [23].
Another possible cause of the gender differences
observed here is adherence, e.g. to which extent the off-
loading advices were followed by the patients. Although
little studied, treatment adherence is believed to have a
substantial impact on the treatment outcome of the
diabetic foot, and apart from identifying biochemical
risk factors there is also a need to reveal individual per-
sonality traits that may pose an increased risk to foot
complications and subsequent LEA.
A ni m p o r t a n ta s p e c ti st h a tf e m a l e sm a yh a v em o r e
efficient wound healing due to the wound healing prop-
erties of estrogen receptor beta [24,25], whereas andro-
gens are implicated to be detrimental to wound healing
[26,27]. This correlates well to previous findings indicat-
ing that male sex is a risk factor for impaired wound
healing [28], and is in line with males being more com-
monly affected by foot ulcers in western countries
Figure 3 Age at event of amputation. A. Mean age at event of
amputation in nondiabetic and diabetic patients. One-way ANOVA:
p < 0.05, Bonferroni post hoc analysis: **p < 0.01 D- all patients vs.
D + all patients, *** p < 0.001 D + female vs. D + male, *p < 0.05 D-
male vs. D + male. Bars represent means + S.E.M. B. Mean age at
event of amputation in diabetic patients. Error bars represent S.E.M.
Figure 4 Foot ulcers and foot care. A. Percentage of patients
with foot ulcers and of patients who received foot care prior to the
amputation. B. Annual distribution of foot ulcers and foot care prior
to amputation.
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more common in men overall [15], whereas that is not
the case in adults with type 1 diabetes.
No sex-dependent age difference was seen in nondia-
betic patients. However, female patients with diabetes
were significantly older when amputated compared to
male diabetic patients. The mean age of female diabetic
patients in Sweden is 2 years higher (63.9 +/- 12.6) than
in male diabetic patients (61.8 +/- 11.9) [31]. However,
even though this difference is significant, it is probably
not sufficient to explain the age difference of more than
10 years seen between the amputated diabetic female
and male patients in this study. Apart from age per se,
increased diabetes duration is an important risk factor
for LEA [29,30]. Type 1 diabetes has an early onset and
is associated with a high risk of LEA [32]; by the age of
65 years the cumulative risk for LEA was 10% in women
and 20.7% in men with type1 diabetes [12]. The diabetes
type and duration in our study cohort was unknown.
However, in view of other Swedish studies there is a
high probability that many patients in our cohort suf-
fered from type 1 diabetes and that males were more
commonly affected. This would mean that many of the
male subjects had an earlier onset of diabetes, and
hence an increased diabetes duration when undergoing
LEA. It is important to keep in mind that many patients
with type 1 diabetes have had a diabetes duration of 50
years or more at the age of 65 years. Moreover, it
should be noted that the mean and median ages in the
amputated females were remarkably high (81.5 and 84
years, respectively). In 2006, the mean life expectancy of
the Swedish population was 82.8 years for females and
78.4 years for males [33], indicating that > 50% of the
female diabetic patients were older than the mean
expected maximum age when amputated. Information
on blood pressure or blood lipid levels was not available
in this patient material, but data from NDR, the Swedish
national diabetes registry, revealed that females have less
well controlled lipids and blood pressure (OR for male
vs. female: blood pressure < = 130/80 mmHg = 1.05; S-
cholesterol < 4.5 mmol/L = 1.8; LDL-cholesterol mmol/
L < 2.5 = 1.28; S-triglycerides < 1.7 = 1.08) [34]. This
information would rather indicate an increased risk of
LEA in female patients suffering from diabetes, as PVD
is a risk factor of amputations [2,29,30]. Nevertheless,
female and male patients with diabetes were equally
affected by CVD, but the overall mean age differed
between the sexes, with female diabetic patients being
significantly older. Consistent with previous data, this
suggests that females can be protected from develop-
ment of CVD decades after menopause [35].
Diabetic nephropathy is a major diabetic complication
and a leading cause of end-stage renal disease [36].
Renal disorders are associated with an increased risk of
neuropathy and PVD [8] and an increased risk of devel-
oping foot complications, including foot ulcers, infec-
tions, gangrene and LEA [19,30,37-39]. In this study, we
found that diabetic patients who were amputated were
s i g n i f i c a n t l ym o r ea f f e c t e db yk i d n e yd i s o r d e r sc o m -
pared to nondiabetic patients. Furthermore, there was a
trend towards more kidney disorders in male diabetic
patients, which correlates well with the increased risk of
LEA observed in this group. It has previously been sug-
gested that the rate of foot complications in diabetic
patients with end-stage renal disease and peritoneal dia-
lysis might be reduced by a multidisciplinary approach
and the early intervention of a chiropodist [40].
Figure 5 Comorbidities. A. Distribution of comorbidities in
nondiabetic and diabetic patients. Unpaired t test: ***p < 0.001 D-
vs. D+. B. Distribution of comorbidities in diabetic female and male
patients. Unpaired t test: *p < 0.05 F vs.M .
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foot ulcers prior to amputation in patients with diabetes,
indicating that once a foot ulcer is present the risk of
LEA is similar in females and males. Nevertheless,
delayed wound healing in male patients suggests
increased vulnerability to ulcer infections, indicating
that this could be a valid contributing factor to the sig-
nificantly higher number of male patients affected by
foot infections in our study. Notably, although female
and male patients had the same prevalence of foot
ulcers, only one fifth of the female patients who were
amputated had been treated at the foot clinic at the
DEMD at KS during the study period, compared to
more than one third of the male patients. In a survey of
the prevalence of diabetic foot ulcers in Stockholm
county (1999, not published) around 3% of the diabetic
population in primary care were treated for a foot ulcer
at a given time. Only one third of all patients with foot
ulcers were referred from the primary care. It is possible
that foot ulcers in the older female patients were diag-
nosed as being primarily of vascular and not of diabetic
origin, and therefore were not referred to the DEMD,
whereas the men, who were approximately 10 years
younger, were diagnosed with neuro-ischaemic diabetic
foot ulcers and thus referred directly to the DEMD. As
mentioned previously, there was no sex difference in the
prevalence of diagnosed PVD, as opposed to what
would be expected if the female patients had more
ischaemic foot ulcers. Ischaemic foot ulcers are corre-
lated to a more acute disease course and commonly
require acute amputations [41], hence, these patients
may not have the chance to receive preventive foot care
in time. There is also a possibility that the female
patients did more self-care, which to some degree could
prevent complicated ulceration [42]. However, the large
multi-centre American TRIAD study on a cohort of
8763 diabetic patients found no gender difference in the
health behavior and amount of self-care in diabetic
patients [43]. These conflicting findings might be related
to ethnic differences, thus, gender and its impact of pro-
tective self-care remains speculative.
Neuropathy is a major risk factor for foot ulcers. In a
recent study, Kärvestedt and colleagues [15] investigated
diabetic subjects from a geographically defined popula-
tion from Sundbyberg, a region which is part of the
catchment area of KS, where 3.5% of the population
between 40 and 70 suffered from diabetes. In this popu-
lation 90% of the diabetic subjects had type 2 diabetes,
and 34% of the patients with type 2 diabetes were
affected by peripheral sensory neuropathy. This and
other studies [44-47] suggest that many patients in our
cohort were affected by neuropathy. Autonomic neuro-
pathy increases the risk of ulceration by causing anhi-
drosis and oedema of the foot [48], and peripheral
sensory polyneuropathy reduce the protective sensation
of the distal limbs [49]. It has been proposed that per-
ipheral neuropathy is associated with altered vascular
function and endoneural hypoxia caused by PVD
[50,51]. Furthermore, the nervous system interacts with
the immune system [52,53], suggesting that the local
immunity of diabetic patients with neuropathy may be
altered. In line with this, diabetic patients are at a
greater risk of severe infections during vascular surgery
[54]. Consistently, we here report that the prevalence of
infections of the foot prior to amputation was higher in
diabetic compared to nondiabetic patients, notably with
diabetic men being more commonly affected compared
to diabetic women.
Our study has several strengths. Since all patients who
were amputated at KS had their case reports read
through, it is unlikely that any diabetic patients were
missed in the cohort. This procedure also provided reli-
able identification of additional diagnoses and foot ulcers
compared to interviews or self-reports. A limitation of
our study was that the additional diagnoses and foot sta-
t u so fp a t i e n t sa m p u t a t e da tD Sw e r en o tk n o w n ,t h u s ,
these patients could not be used for analyses of comor-
bidities or foot status. However, as the patient group
amputated at DS was referred due to geographic location
only, it was expected to be similar to the group ampu-
tated at KS in respect of clinical characteristics. The dia-
betes type, duration, and the neuropathy status of the
diabetic patients were unknown. However, since the
Swedish diabetic population is well studied, it is possible
to make valid assumptions based on previous studies.
Another limitation was the coinciding change from paper
case reports to a digital case report system before and
during the beginning of the investigated time period.
This made parts of the older case reports difficult to
obtain, and it is possible that some amputations per-
formed during the beginning of the study period went
undetected. At KS, there were five basic levels of amputa-
tions registered (NHQ16, NHQ14, NGQ19, NGQ09,
NFQ19), and to ensure that all registered amputations
were correctly labeled, all codes must be compared to the
surgeon’s notes. This was not done in this study, which is
a limitation. However, the recording of amputation codes
has been computer based since many years, and is
checked by a secretary as it is the base for the internal
economic compensation system. This should limit the
risk of erroneous reporting.
According to the consensus guidelines of foot care,
better treatment outcomes are expected if all patients
with problems related to the diabetic foot are treated by
multidisciplinary treatment teams. However, our study
revealed that despite the establishment of consensus
guidelines, many patients who subsequently underwent
amputations at KS had not received any
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Page 9 of 11multidisciplinary treatment through the DEMD. Never-
theless, the reduced major amputation rate indicates
knowledge and awareness of the consensus guidelines
on treatment of the diabetic foot. It cannot be excluded
that amputation rates could be further reduced if all
patients had been referred to the multidisciplinary foot
team early, when the first symptoms of diabetes-related
foot complications appeared. More efforts can be put
into ensuring that patients being at risk of LEA will
receive preventive foot care in time, and specialist treat-
ment as soon as a foot ulcer is noticed, preferably within
two weeks. These actions would possibly lead to further
prevention of amputations in diabetic patients.
Conclusions
￿ The rate of major amputations in diabetic patients
decreased with approximately 60% between 2001 and
2006.
￿ Diabetic patients who were amputated had a higher
prevalence of common comorbidities, including foot
infections and kidney disorders, compared to amputated
nondiabetic patients. Diabetic patients also underwent
more re- and double amputations.
￿ Male diabetic patients were 10 years younger at the
event of amputation, underwent a larger number of re-
amputations and had a higher prevalence of infected
foot ulcers compared to female diabetic patients.
￿ Only 30% of the patients had been in contact with
the multidisciplinary foot team at the Department of
Endocrinology, Metabolism and Diabetes before
amputation.
￿ T h ea m p u t a t i o nr a t ec o u l dp o s s i b l yb ef u r t h e r
reduced if all patients at risk of LEA were referred to
the multidisciplinary foot team in order to get specialist
treatment.
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